Which closed-end funds own Arcutis Biotherapeutics Inc?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $14.1M. Security type: common equity. Country: United States. CUSIP 03969K108 · ISIN US03969K1088 · ticker ARQT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQH abrdn Healthcare Investors | Healthcare | 0.70% | $9.6M | 364,356 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.66% | $4.5M | 172,867 sh | $690M | 3.5% discount | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “ARQT” → · Compare two funds’ portfolios →